News

Robert Webster Presents at the Congress of Neurological Surgeons

Oct 7, 2018

Virtuoso founder Robert Webster visits the 2018 Congress of Neurological Surgeons to present neurosurgical applications of the Virtuoso technology.

Mark Pickrell Presents at MedTech Strategist

Oct 2, 2018

Virtuoso founder Mark Pickrell visits MedTech Strategist to present Virtuoso's technology to potential investors.

Duke Herrell Presents at the World Congress of Endourology

Sept 20, 2018

Virtuoso founder Duke Herrell visits the 2018 World Congress of Endourology to present an update on the Virtuoso technology for urologic applications.

Virtuoso Founders Present at American Urologic Association

May 21, 2018

Robert Webster and Duke Herrell visit the American Urologic Association's Annual Meeting to present about Virtuoso's potential treatment for benign prostatic hyperplasia.

Virtuoso Receives STTR Phase I Grant

December 15, 2017

Virtuoso Surgical receives an STTR award from the National Heart, Lung, and Blood Institute. The award will fund application of Virtuoso's technology to treat central airway obstructions.

Virtuoso Receives SBIR Matching Grant

October 30, 2017

Virtuoso Surgical receives an SBIR Matching Grant Award from Launch Tennessee. The State award will accelerate progress and promote growth in Tennessee.

Virtuoso Receives SBIR Phase II Grant

September 4, 2017

Virtuoso Surgical receives a Notice of Award from the National Institute of Biomedical Imaging and Bioengineering. The NIH award is expected to fund prototype development, testing, and regulatory approval efforts for a two-year period.

Virtuoso Begins Formal Operations

September 1, 2017

Virtuoso Surgical begins formal operations, opening its engineering offices and engineering laboratory in Nashville, Tennessee for development of its endoscopic surgical device.

Virtuoso Surgical, Inc. Founded

April 27, 2016

Virtuoso Surgical, Inc. is incorporated by Dr. Webster, Dr. Herrell, Dr. Hendrick, and Mark Pickrell to commercialize a surgical device using concentric tube technology.